Cargando…

Amblyopia Treatment Efficacy in Anisometropia

PURPOSE: To compare the treatment efficacy of optical correction and occlusion therapy and/or penalization for different anisometropic refractive errors (hyperopic, myopic, and mixed). METHODS: Medical records of 51 patients with anisometropic amblyopia managed by both optical correction and occlusi...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Ammari, Hessa M, Al Shamlan, Fatemah T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901119/
https://www.ncbi.nlm.nih.gov/pubmed/31824133
http://dx.doi.org/10.2147/OPTH.S224463
_version_ 1783477452492767232
author Al Ammari, Hessa M
Al Shamlan, Fatemah T
author_facet Al Ammari, Hessa M
Al Shamlan, Fatemah T
author_sort Al Ammari, Hessa M
collection PubMed
description PURPOSE: To compare the treatment efficacy of optical correction and occlusion therapy and/or penalization for different anisometropic refractive errors (hyperopic, myopic, and mixed). METHODS: Medical records of 51 patients with anisometropic amblyopia managed by both optical correction and occlusion therapy and/or penalization were evaluated retrospectively. Patients were categorized into hyperopic, myopic or mixed anisometropia groups. Cycloplegic refraction, spherical anisometropia, baseline visual acuity, baseline interocular difference, final visual acuity and final interocular difference were analyzed to assess association between type of anisometropia with both resolution of anisometropic amblyopia and the time required to achieve it. RESULTS: Baseline visual acuity of the amblyopic was 0.94±0.47 in the hyperopic group; 1.12±0.56, in the myopic group; and 1.08 ±0.39 in the mixed group. Final visual acuity in the amblyopic eye was 0.34±0.30 in the hyperopic group, 0.78±0.59 in the myopic group, and 0.78±0.56 in the mixed group. The difference in final visual acuity in the amblyopic eye between the groups was significant (P=0.014). The amblyopia was improved in 50% of patients in the hyperopic group, 23.8% in the myopic group, and 14.3% in the mixed group (P=0.081). The type of anisometropia was significantly associated with the improvement of visual acuity in the amblyopic eyes (P=0.044). The mean time for amblyopia improvement was 16.50±10.52 months in the hyperopic groups, 15.60±12.44 months in the myopic group, and 21.00±21.21 months in the mixed group (P=0.947). CONCLUSION: Lower amounts of hyperopic anisometropia are as amblyogenic as higher amounts of myopic or mixed anisometropia. Mean improvement in visual acuity of an amblyopic eye with both optical correction, occlusion therapy and/or penalization is higher in patients with hyperopic anisometropia in comparison with myopic or mixed anisometropia. No significant difference was found in the time required to achieve improvement between the study groups.
format Online
Article
Text
id pubmed-6901119
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-69011192019-12-10 Amblyopia Treatment Efficacy in Anisometropia Al Ammari, Hessa M Al Shamlan, Fatemah T Clin Ophthalmol Original Research PURPOSE: To compare the treatment efficacy of optical correction and occlusion therapy and/or penalization for different anisometropic refractive errors (hyperopic, myopic, and mixed). METHODS: Medical records of 51 patients with anisometropic amblyopia managed by both optical correction and occlusion therapy and/or penalization were evaluated retrospectively. Patients were categorized into hyperopic, myopic or mixed anisometropia groups. Cycloplegic refraction, spherical anisometropia, baseline visual acuity, baseline interocular difference, final visual acuity and final interocular difference were analyzed to assess association between type of anisometropia with both resolution of anisometropic amblyopia and the time required to achieve it. RESULTS: Baseline visual acuity of the amblyopic was 0.94±0.47 in the hyperopic group; 1.12±0.56, in the myopic group; and 1.08 ±0.39 in the mixed group. Final visual acuity in the amblyopic eye was 0.34±0.30 in the hyperopic group, 0.78±0.59 in the myopic group, and 0.78±0.56 in the mixed group. The difference in final visual acuity in the amblyopic eye between the groups was significant (P=0.014). The amblyopia was improved in 50% of patients in the hyperopic group, 23.8% in the myopic group, and 14.3% in the mixed group (P=0.081). The type of anisometropia was significantly associated with the improvement of visual acuity in the amblyopic eyes (P=0.044). The mean time for amblyopia improvement was 16.50±10.52 months in the hyperopic groups, 15.60±12.44 months in the myopic group, and 21.00±21.21 months in the mixed group (P=0.947). CONCLUSION: Lower amounts of hyperopic anisometropia are as amblyogenic as higher amounts of myopic or mixed anisometropia. Mean improvement in visual acuity of an amblyopic eye with both optical correction, occlusion therapy and/or penalization is higher in patients with hyperopic anisometropia in comparison with myopic or mixed anisometropia. No significant difference was found in the time required to achieve improvement between the study groups. Dove 2019-12-05 /pmc/articles/PMC6901119/ /pubmed/31824133 http://dx.doi.org/10.2147/OPTH.S224463 Text en © 2019 Al Ammari and Al Shamlan. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Al Ammari, Hessa M
Al Shamlan, Fatemah T
Amblyopia Treatment Efficacy in Anisometropia
title Amblyopia Treatment Efficacy in Anisometropia
title_full Amblyopia Treatment Efficacy in Anisometropia
title_fullStr Amblyopia Treatment Efficacy in Anisometropia
title_full_unstemmed Amblyopia Treatment Efficacy in Anisometropia
title_short Amblyopia Treatment Efficacy in Anisometropia
title_sort amblyopia treatment efficacy in anisometropia
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901119/
https://www.ncbi.nlm.nih.gov/pubmed/31824133
http://dx.doi.org/10.2147/OPTH.S224463
work_keys_str_mv AT alammarihessam amblyopiatreatmentefficacyinanisometropia
AT alshamlanfatemaht amblyopiatreatmentefficacyinanisometropia